Advanced search
Publication Cover
International Journal of Nanomedicine Volume 16, 2021 - Issue
Submit an article Journal homepage
55
Views
24
CrossRef citations to date
0
Altmetric
Original Research

RETRACTED ARTICLE: Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer

Jialang Zhuang1 Biobank, Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, People’s Republic of China;2 Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518035, People’s Republic of China
,
Siqi Chen1 Biobank, Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, People’s Republic of China;3 Graduate School of Guangzhou Medical University, Guangzhou, 510182, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-0659-4113
ORCID Icon,
Ye Hu1 Biobank, Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, People’s Republic of China
,
Fan Yang1 Biobank, Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, People’s Republic of China
,
Qin Huo1 Biobank, Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, People’s Republic of China
&
Ni Xie1 Biobank, Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7167-9343
ORCID Icon
Pages 1961-1976 | Published online: 08 Mar 2021

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ronghua Tan, Danlei Tian, Jiaoyan Liu, Congcong Wang & Ying Wan. (2021) Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy. International Journal of Nanomedicine 16, pages 4527-4544.
Read now

Articles from other publishers (23)

Milad Ashrafizadeh, Ali Zarrabi, Ashkan Bigham, Afshin Taheriazam, Yalda Saghari, Sepideh Mirzaei, Mehrdad Hashemi, Kiavash Hushmandi, Hassan Karimi‐Maleh, Ehsan Nazarzadeh Zare, Esmaeel Sharifi, Yavuz Nuri Ertas, Navid Rabiee, Gautam Sethi & Mingzhi Shen. (2023) (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy. Medicinal Research Reviews.
Crossref
Chandrasekharan Rajalekshmi Dhanya, Aarcha Shanmugha Mary & Maya Madhavan. (2022) Aptamer‐siRNA chimeras: Promising tools for targeting HER2 signaling in cancer . Chemical Biology & Drug Design 101:5, pages 1162-1180.
Crossref
Anastasiya N. Shishparenok, Vitalina V. Furman & Dmitry D. Zhdanov. (2023) DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors. Cancers 15:7, pages 2151.
Crossref
Victoriya Popova, Yuliya Poletaeva, Alexey Chubarov, Dmitrii Pyshnyi & Elena Dmitrienko. (2023) Doxorubicin-Loaded Silica Nanocomposites for Cancer Treatment. Coatings 13:2, pages 324.
Crossref
Ruma Rani, Parth Malik, Sunena Dhania & Tapan Kumar Mukherjee. (2023) Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment. Pharmaceutics 15:1, pages 227.
Crossref
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari, Seyed Hesamoddin Bidooki, Vahideh Javadian Ghaleh, Shamin rezaei, Elahe Sadat Hejazi, Amirabbas Kakavand, Mitra Behroozaghdam, Abolfazl Movafagh, Afshin Taheriazam, Mehrdad Hashemi & Saeed Samarghandian. (2022) siRNA and targeted delivery systems in breast cancer therapy. Clinical and Translational Oncology 25:5, pages 1167-1188.
Crossref
Azadeh Hekmat, Luciano Saso, Viney Lather, Deepti Pandita, Irena Kostova & Ali Akbar Saboury. (2022) Recent Advances in Nanomaterials of Group XIV Elements of Periodic Table in Breast Cancer Treatment. Pharmaceutics 14:12, pages 2640.
Crossref
Javad Parnian, Leila Ma’mani, Mohamad Reza Bakhtiari & Maliheh Safavi. (2022) Overcoming the non-kinetic activity of EGFR1 using multi-functionalized mesoporous silica nanocarrier for in vitro delivery of siRNA. Scientific Reports 12:1.
Crossref
Min Guo, Ying Tang, Liang Hua, Wanling Li, Guifang Gong, Yali Zhu, Bing Zhu & Yu Xia. (2022) Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy. Advances in Materials Science and Engineering 2022, pages 1-9.
Crossref
Zhongtao Li, Jing Guo, Guiqiang Qi, Meng Zhang & Liguo Hao. (2022) pH-Responsive Drug Delivery and Imaging Study of Hybrid Mesoporous Silica Nanoparticles. Molecules 27:19, pages 6519.
Crossref
Ying Li, Guoxing Deng, Xianlong Hu, Chenyang Li, Xiaodong Wang, Qinchang Zhu, Kai Zheng, Wei Xiong & Haiqiang Wu. (2022) Recent advances in mesoporous silica nanoparticle-based targeted drug-delivery systems for cancer therapy. Nanomedicine 17:18, pages 1253-1279.
Crossref
Simona Campora & Giulio Ghersi. (2022) Recent developments and applications of smart nanoparticles in biomedicine. Nanotechnology Reviews 11:1, pages 2595-2631.
Crossref
Arpita Paul, Anuraag Muralidharan, Avirup Biswas, B Venkatesh Kamath, Alex Joseph & Angel Treasa Alex. (2022) siRNA therapeutics and its challenges: Recent advances in effective delivery for cancer therapy. OpenNano 7, pages 100063.
Crossref
Mahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, Sima Orouei, Kiavash Hushmandi, Maliheh Entezari, Mehrdad Hashemi, Amir Reza Aref, Michael R. Hamblin, Hui Li Ang, Alan Prem Kumar, Ali Zarrabi & Saeed Samarghandian. (2022) Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy. Life Sciences 298, pages 120463.
Crossref
Valentina Foglizzo & Serena Marchiò. (2022) Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy. Cancers 14:10, pages 2473.
Crossref
W N Safitriono, W A Lestari, S Wahyuningsih, V Suryanti, S Gomez-Ruiz & F R Wibowo. (2022) Synthesized and release study of labelled small mesoporous silica nanoparticle as theranostic material. Journal of Physics: Conference Series 2190:1, pages 012035.
Crossref
W A Lestari, S Wahyuningsih, S Gomez-Ruiz & F R Wibowo. (2022) Drug loading ability and release study of various size small mesoporous silica nanoparticle as drug carrier. Journal of Physics: Conference Series 2190:1, pages 012032.
Crossref
Merve Karpuz, Miray İlhan, Hazal Ezgi Gültekin, Emre Ozgenc, Zeynep Şenyiğit & Evren Atlihan-Gundogdu. 2022. Applications of Nanovesicular Drug Delivery. Applications of Nanovesicular Drug Delivery 219 244 .
Rajesh Salve, Pramod Kumar, Kavita R. Gajbhiye, Rajnigandha A. Shende, Bhushan P. Chaudhari & Virendra Gajbhiye. 2022. Stimuli-Responsive Nanocarriers. Stimuli-Responsive Nanocarriers 237 264 .
Saffiya Habib & Moganavelli Singh. 2022.
QingQing Leng, Yue Li, Ping Zhou, Kang Xiong, Yun Lu, YongXia Cui, BiQiong Wang, ZhouXue Wu, Ling Zhao & ShaoZhi Fu. (2021) Injectable hydrogel loaded with paclitaxel and epirubicin to prevent postoperative recurrence and metastasis of breast cancer. Materials Science and Engineering: C 129, pages 112390.
Crossref
Miguel Gisbert-Garzarán & María Vallet-Regí. (2021) Redox-Responsive Mesoporous Silica Nanoparticles for Cancer Treatment: Recent Updates. Nanomaterials 11:9, pages 2222.
Crossref
Ana Raquel Neves, Tânia Albuquerque, Rúben Faria, Milan Paul, Swati Biswas, Ângela Sousa & Diana Costa. (2021) Development of Tailor-Made Dendrimer Ternary Complexes for Drug/Gene Co-Delivery in Cancer. Pharmaceutics 13:8, pages 1256.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.